Discriminating the effects of Cannabis sativa and Cannabis indica: A web survey of medical cannabis users

Journal of Alternative and Complementary Medicine

Volumn 20, Issue 10, 2014, Pages 787-791

  Pearce, Daniel D ^a   Mitsouras, Katherine ^b   Irizarry, Kristopher J ^b  

^a LOMA LINDA UNIVERSITY HEALTH   (United States)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; MEDICAL CANNABIS;

ANALGESIA; APPETITE; ARTHRALGIA; ARTICLE; CANNABIS USE; DRUG EFFECT; ENERGY; EUPHORIA; GLAUCOMA; HEADACHE; HEALTH SURVEY; HUMAN; INSOMNIA; INTERNAL CONSISTENCY; LETHARGY; MAJOR CLINICAL STUDY; NAUSEA; NEUROPATHY; ONLINE SYSTEM; PARANOIA; SEDATION; SEIZURE; SLEEP; SPASTICITY; TREATMENT INDICATION; WEIGHT REDUCTION; ADULT; FEMALE; INTERNET; MALE; PHYTOTHERAPY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; CANNABIS; FEMALE; HEALTH SURVEYS; HUMANS; INTERNET; MALE; MEDICAL MARIJUANA; PHYTOTHERAPY; YOUNG ADULT;

EID: 84912114721     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2013.0190     Document Type: Article

References (18)

1. Elphick MR, Egertova M. The neurobiology and evolution of cannabinoid signalling. Philos Trans R Soc Lond B Biol Sci 2001;356:381-408.
2. Parker LA, Mechoulam R, Schlievert C. Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats. Neuroreport 2002;13:567-570.
3. Vignot S, Besse B, de la Motte Rouge T, et al. [Cannabis and cancer]. Bull Cancer 2006;93:163-170.
4. Hillig K, Mahlberg P. A chemotaxonamic analysis of cannabinoid variation in cannabis (Cannabaceae). Am J Botany 2004;91:966-975.
5. Upton R, ElSohly M, Romm A, Russo E, Sexton M, eds. Cannabis Inflorescence, Cannabis spp. Scotts Valley: American Herbal Pharmacopoeia; 2013.
6. ElSohly MA, Ross SA, Mehmedic Z, et al. Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980-1997. J Forensic Sci 2000;45:24-30.
7. Ware MA, Wang T, Shapiro S, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ. 2010;182:E694-701.
8. Vann RE, Gamage TF, Warner JA, et al. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol. Drug Alcohol Depend. 2008;94:191-198.
9. Rog DJ, Nurmikko TJ, Young CA. Oromucosal delta9- tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Clin Ther 2007;29:2068-2079.
10. Nicholson AN, Turner C, Stone BM, Robson PJ. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 2004;24:305-313.
11. Fattore L, Fratta W. How important are sex differences in cannabinoid action? Br J Pharmacol. 2010;160:544-548.
12. Lopez HH. Cannabinoid-hormone interactions in the regulation of motivational processes. Horm Behav. 2010;58: 100-110.
13. Viveros MP, Marco EM, Lopez-Gallardo M, et al. Framework for sex differences in adolescent neurobiology: a focus on cannabinoids. Neurosci Biobehav Rev 2011;35:1740-1751.
14. Kellert BA, Nguyen MC, Nguyen C, et al. Estrogen rapidly attenuates cannabinoid-induced changes in energy homeostasis. Eur J Pharmacol 2009;622:15-24.
15. Ware MA, Adams H, Guy GW. The medicinal use of cannabis in the UK: results of a nationwide survey. Int J Clin Pract 2005;59:291-295.
16. Gieringer D, Hazekamp A. How accurate is potency testing. O'Shaughnessy's. 2011;17.
17. Provision of marijuana and other compounds for scientific research - recommendations of The National Institute on Drug Abuse National Advisory Council. 1998 growth of cannabis is legally restricted. Online document at: http://archives.drugabuse.gov/about/organization/nacda/MarijuanaStatement.html Accessed April 12, 2013.
18. Brill NQ, Crumpton E, Frank IM, et al. The marijuana problem. Ann Intern Med. 1970;73:449-465.